Showing 161 - 180 results of 19,226 for search '(( significant ((level decrease) OR (mean decrease)) ) OR ( significantly a decrease ))', query time: 0.80s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167

    Mean amplitude values during a complete 360° rotation for the external oblique muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
  8. 168

    Mean amplitude values during a complete 360° rotation for the internal oblique muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
  9. 169

    Mean amplitude values during a complete 360° rotation for the rectus abdominis muscle. by Christoph Anders (4068499)

    Published 2024
    “…The values for the movement half-phase with decreasing load are mirrored to enable a direct comparison between both movement half-phases. …”
  10. 170
  11. 171
  12. 172
  13. 173

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    “…Secondary outcomes included performance, fear of movement, and perceived ankle instability, measured using the side-hop test, the Tampa Scale for Kinesiophobia (TSK), and the Cumberland Ankle Instability Tool (CAIT), respectively. Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

    Published 2025
    “…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”